[go: up one dir, main page]

AU2003275093A1 - Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof - Google Patents

Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof

Info

Publication number
AU2003275093A1
AU2003275093A1 AU2003275093A AU2003275093A AU2003275093A1 AU 2003275093 A1 AU2003275093 A1 AU 2003275093A1 AU 2003275093 A AU2003275093 A AU 2003275093A AU 2003275093 A AU2003275093 A AU 2003275093A AU 2003275093 A1 AU2003275093 A1 AU 2003275093A1
Authority
AU
Australia
Prior art keywords
phenylpyrazoles
modulators
intermediates
useful
making
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003275093A
Other versions
AU2003275093A8 (en
Inventor
Keith Drouet
Katie Elwell
Konrad Feichtinger
Stefan Horns
Max Ray
Bradley Teegarden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arena Pharmaceuticals Inc
Original Assignee
Arena Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arena Pharmaceuticals Inc filed Critical Arena Pharmaceuticals Inc
Publication of AU2003275093A1 publication Critical patent/AU2003275093A1/en
Publication of AU2003275093A8 publication Critical patent/AU2003275093A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003275093A 2002-09-24 2003-09-22 Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof Abandoned AU2003275093A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41329902P 2002-09-24 2002-09-24
US60/413,299 2002-09-24
PCT/US2003/029736 WO2004028450A2 (en) 2002-09-24 2003-09-22 Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof

Publications (2)

Publication Number Publication Date
AU2003275093A1 true AU2003275093A1 (en) 2004-04-19
AU2003275093A8 AU2003275093A8 (en) 2004-04-19

Family

ID=32043230

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275093A Abandoned AU2003275093A1 (en) 2002-09-24 2003-09-22 Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof

Country Status (2)

Country Link
AU (1) AU2003275093A1 (en)
WO (1) WO2004028450A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06000795A (en) 2003-07-22 2006-08-23 Arena Pharm Inc Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related therto.
EP1727803B3 (en) 2004-03-23 2014-04-23 Arena Pharmaceuticals, Inc. Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl)phenyl] ureas and intermediates thereof
PE20061130A1 (en) 2004-11-19 2007-01-05 Arena Pharm Inc 3-PHENYL-PIRAZOLE DERIVATIVES AS MODULATORS OF THE SEROTONIN 5-HT2A RECEPTOR
AR052886A1 (en) * 2005-01-26 2007-04-11 Arena Pharm Inc PROCEDURES TO PREPARE PHENYLPIRAZOL REPLACED UREAS AND TO OBTAIN YOUR SYNTHESIS INTERMEDIARIES
JP5389642B2 (en) 2006-05-18 2014-01-15 アリーナ ファーマシューティカルズ, インコーポレイテッド 3-pyrazolyl-benzamido-4-ethers, secondary amines and derivatives thereof as modulators of 5-HT2A serotonin receptors useful for the treatment of disorders associated with 5-HT2A serotonin receptors
ES2543718T3 (en) 2006-05-18 2015-08-21 Arena Pharmaceuticals, Inc. Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the serotonin 5-HT2A receptor
ES2536762T3 (en) 2006-05-18 2015-05-28 Arena Pharmaceuticals, Inc. Primary amines and their derivatives as 5-HT2A serotonin receptor modulators useful for the treatment of disorders related to this
TWI415845B (en) 2006-10-03 2013-11-21 Arena Pharm Inc Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
ES2421237T7 (en) 2007-08-15 2013-09-30 Arena Pharmaceuticals, Inc. Imidazo [1,2-a] pyridine derivatives as modulators of the serotonergic 5ht2a receptor in the treatment of disorders related thereto
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
PT2364142T (en) 2008-10-28 2018-04-23 Arena Pharm Inc Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
US8980891B2 (en) 2009-12-18 2015-03-17 Arena Pharmaceuticals, Inc. Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
MX388281B (en) 2015-06-12 2025-03-11 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder
HK1247555A1 (en) 2015-07-15 2018-09-28 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
EP4631938A1 (en) 2022-12-08 2025-10-15 Shionogi & Co., Ltd Nitrogen-containing heterocycle with serotonin receptor-binding activity and carbocyclic derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682379B1 (en) * 1991-10-09 1994-02-11 Rhone Poulenc Agrochimie NEW FUNGICIDAL PHENYLPYRAZOLES.

Also Published As

Publication number Publication date
WO2004028450A3 (en) 2004-10-07
WO2004028450A2 (en) 2004-04-08
AU2003275093A8 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
AU2003226433A1 (en) Adhesive microstructure and method of forming same
AU2003242024A1 (en) Method of constructing antibody
AU2003900810A0 (en) Method of scheduling
AU2003234419A1 (en) Method of forming manofluidic channels
AU2003299892A1 (en) Glass-ceramic material and method of making
AU2003275093A1 (en) Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof
AU2003211625A1 (en) Method of modifying protein properties
AU2003297441A1 (en) Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
AU2003282558A1 (en) Nanopellets and method of making nanopellets
AU2003273965A1 (en) Process for making bicalutamide and intermediates thereof
AU2003244297A1 (en) Method of producing flat glass
AU2003247827A1 (en) Methods to assess quality of microarrays
AU2003277596A1 (en) Method of deuterization
AU2003258664A1 (en) Method of colouring porous material
AU2003226885A1 (en) Novel method for production of dna biochips and applications thereof
WO2004089526A8 (en) Methods of providing product consistency
AUPS096002A0 (en) Method of construction
AU2003257953A1 (en) Internally colored block and process
AU2003216354A1 (en) Modulators of paraptosis and related methods
AU2003288762A1 (en) Method and apparatus of hemorheometer
AU2003264491A1 (en) Method of measuring collagen
AU2003301692A1 (en) Essential dna enclosed proteins of drosphophilia melanogaster
AU2002306406A1 (en) Dna constructs for cytoplasmic and mithochondrial expression and methods of making and using same
AU2003267012A1 (en) Method of colouring porous material
AU2003224716A1 (en) Method of tensile flow forming

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase